A Single-Arm Study of Sintilimab and Disitamab Vedotin for Locally Advanced Eyelid Sebaceous Gland Carcinoma
Clinical trial NCT07740993 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07740993
- Sponsor
- West China Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-10-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.